EFPAC TAB STRIP

Searching for where to buy Efpac Tab Strip in Ghana? Want to know Efpac Tab Strip price in Ghana? Shop Efpac Tab Strip from healthonlineghana.com, Connecting You to Online Pharmacies in Ghana - Shop them at the best price from Health Online Ghana. Health Online, Ghana’s First Online Platform for Pharmacies in Ghana. Enjoy Cash On Delivery | Secure Payment | Free Health Consultation from Health Online's Online Pharmacists in Ghana. Buy from a pharmacy in Accra or a pharmacy in Ghana. Nationwide Delivery available.

EFPAC is used for the symptomatic relief of headaches, colds, catarrh, sore throats, menstrual cramps, joint, muscle and rheumatic pain, dental pain, and mild to moderate bodily pains.EFPAC also reduces body temperature during treatment of mild febrile conditions such as flu. 

Composition

Each tablet contains:

• Acetaminophen (Paracetamol) 250mg
• Aspirin 150mg
• Caffeine 30mg

Actions

Paracetamol and Aspirin have analgesic and antipyretic properties. Caffeine is a mild stimulant of the Central Nervous System, and produces a condition of alertness and increased mental activity. The combination of paracetamol, aspirin and caffeine in EFPAC offers enhanced pain relief without sedation.

Dosage and Administration

For adults 16 years and above: 2 tablets every 4 to 6 hours (3 or 4 times daily), preferably after meals. Should symptoms persist after 2 days, immediate medical attention must be sought.

Warnings

It is not recommended to take EFPAC tablets with other paracetamol-containing medicines.

Precautions

Use in Children: – The use of aspirin has been implicated in some cases of Reye’s syndrome. Thus, EFPAC is not recommended for patients under 16 years of age.
Asthmatic or Hypersensitive Patients – Some persons, especially those with asthma, or chronic rhinitis, exhibit notable hypersensitivity reactions to aspirin. Thus EFPAC is generally not recommended for such patients.

Use in Pregnancy: – Some studies suggest that aspirin and other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) could affect normal formation and development of foetus, especially during the first three months of pregnancy. EFPAC is thus not recommended for pregnant women.